ESCRT-III Component CHMP4C Attenuates Cardiac Hypertrophy by Targeting the Endo-Lysosomal Degradation of EGFR.
Ao LiuHuilin XieFangyan TianPei-Yuan BaiHaobo WengYu LiuWen LiuLu TangHongmin YouNianwei ZhouXianhong ShuPublished in: Hypertension (Dallas, Tex. : 1979) (2023)
CHMP4C represses cardiac hypertrophy by modulating lysosomal degradation of EGFR and is a potential therapeutic candidate for cardiac hypertrophy.